Carl Zeiss Meditec Resultados de beneficios anteriores
Pasado controles de criterios 2/6
Carl Zeiss Meditec ha aumentado sus beneficios a una tasa media anual de 19.1%, mientras que los beneficios de la industria de Medical Equipment han experimentado un crecimiento de 4.3% anual. Los ingresos han ido creciendo a una tasa media de 10.3% al año. La rentabilidad financiera de Carl Zeiss Meditec es de 12.8%, y sus márgenes netos son de 13.2%.
Información clave
19.1%
Tasa de crecimiento de los beneficios
19.1%
Tasa de crecimiento del BPA
Crecimiento de la industria Medical Equipment | 4.3% |
Tasa de crecimiento de los ingresos | 10.3% |
Rentabilidad financiera | 12.8% |
Margen neto | 13.2% |
Próxima actualización de resultados | 08 May 2024 |
Actualizaciones de resultados anteriores recientes
Recent updates
Is There Now An Opportunity In Carl Zeiss Meditec AG (ETR:AFX)?
Mar 24Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?
Mar 11Slowing Rates Of Return At Carl Zeiss Meditec (ETR:AFX) Leave Little Room For Excitement
Feb 12Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)
Jan 29What Does Carl Zeiss Meditec AG's (ETR:AFX) Share Price Indicate?
Dec 08Carl Zeiss Meditec (ETR:AFX) Is Experiencing Growth In Returns On Capital
Nov 08Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 37% Above Its Share Price
Oct 24Is Carl Zeiss Meditec (ETR:AFX) A Risky Investment?
Sep 24Should You Investigate Carl Zeiss Meditec AG (ETR:AFX) At €85.72?
Sep 08Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)
Jul 24We Like These Underlying Return On Capital Trends At Carl Zeiss Meditec (ETR:AFX)
Jun 19Should You Think About Buying Carl Zeiss Meditec AG (ETR:AFX) Now?
Jun 06Is Now The Time To Put Carl Zeiss Meditec (ETR:AFX) On Your Watchlist?
May 22Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 24% Below Its Share Price
Apr 19Carl Zeiss Meditec (ETR:AFX) Has A Pretty Healthy Balance Sheet
Feb 26Carl Zeiss Meditec's (ETR:AFX) Shareholders Will Receive A Bigger Dividend Than Last Year
Feb 10Here's Why We Think Carl Zeiss Meditec (ETR:AFX) Is Well Worth Watching
Jan 28Carl Zeiss Meditec (ETR:AFX) Has Announced That It Will Be Increasing Its Dividend To €1.10
Jan 12Carl Zeiss Meditec (ETR:AFX) Will Pay A Larger Dividend Than Last Year At €1.10
Dec 29Carl Zeiss Meditec (ETR:AFX) Has Announced That It Will Be Increasing Its Dividend To €1.10
Dec 14What Is Carl Zeiss Meditec AG's (ETR:AFX) Share Price Doing?
Nov 04Calculating The Intrinsic Value Of Carl Zeiss Meditec AG (ETR:AFX)
Oct 18Investors Will Want Carl Zeiss Meditec's (ETR:AFX) Growth In ROCE To Persist
Sep 12Carl Zeiss Meditec (ETR:AFX) Seems To Use Debt Rather Sparingly
Aug 25Returns On Capital At Carl Zeiss Meditec (ETR:AFX) Have Hit The Brakes
May 30Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?
Feb 27Carl Zeiss Meditec's (ETR:AFX) Returns Have Hit A Wall
Feb 08Here's Why We Think Carl Zeiss Meditec (ETR:AFX) Is Well Worth Watching
Dec 12Carl Zeiss Meditec (ETR:AFX) Has Some Way To Go To Become A Multi-Bagger
Nov 06If You Like EPS Growth Then Check Out Carl Zeiss Meditec (ETR:AFX) Before It's Too Late
Sep 06Investors Met With Slowing Returns on Capital At Carl Zeiss Meditec (ETR:AFX)
Aug 08Here's Why We Think Carl Zeiss Meditec AG's (ETR:AFX) CEO Compensation Looks Fair for the time being
May 21Why Carl Zeiss Meditec's (ETR:AFX) Shaky Earnings Are Just The Beginning Of Its Problems
May 18Capital Allocation Trends At Carl Zeiss Meditec (ETR:AFX) Aren't Ideal
Apr 28Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 19% Below Its Share Price
Mar 09How Should Investors Feel About Carl Zeiss Meditec's (ETR:AFX) CEO Remuneration?
Feb 16What Type Of Shareholders Own The Most Number of Carl Zeiss Meditec AG (ETR:AFX) Shares?
Jan 30Desglose de ingresos y gastosBeta
Cómo gana y gasta dinero Carl Zeiss Meditec. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
---|---|---|---|---|
31 Dec 23 | 2,094 | 277 | 509 | 356 |
30 Sep 23 | 2,089 | 290 | 503 | 349 |
30 Jun 23 | 2,080 | 308 | 496 | 343 |
31 Mar 23 | 2,022 | 278 | 483 | 326 |
31 Dec 22 | 1,963 | 307 | 455 | 312 |
30 Sep 22 | 1,903 | 294 | 439 | 291 |
30 Jun 22 | 1,781 | 245 | 417 | 270 |
31 Mar 22 | 1,735 | 264 | 392 | 251 |
31 Dec 21 | 1,688 | 228 | 380 | 238 |
30 Sep 21 | 1,647 | 236 | 365 | 232 |
30 Jun 21 | 1,566 | 235 | 337 | 227 |
31 Mar 21 | 1,388 | 159 | 326 | 225 |
31 Dec 20 | 1,335 | 130 | 334 | 221 |
30 Sep 20 | 1,335 | 122 | 350 | 219 |
30 Jun 20 | 1,400 | 120 | 379 | 212 |
31 Mar 20 | 1,507 | 166 | 400 | 200 |
31 Dec 19 | 1,505 | 170 | 400 | 188 |
30 Sep 19 | 1,459 | 160 | 394 | 173 |
30 Jun 19 | 1,382 | 153 | 381 | 159 |
31 Mar 19 | 1,334 | 129 | 371 | 158 |
31 Dec 18 | 1,310 | 127 | 362 | 157 |
30 Sep 18 | 1,281 | 126 | 354 | 160 |
30 Jun 18 | 1,251 | 124 | 342 | 161 |
31 Mar 18 | 1,216 | 129 | 341 | 156 |
31 Dec 17 | 1,205 | 132 | 341 | 149 |
30 Sep 17 | 1,190 | 134 | 339 | 146 |
30 Jun 17 | 1,154 | 123 | 331 | 138 |
31 Mar 17 | 1,135 | 112 | 319 | 132 |
31 Dec 16 | 1,106 | 113 | 311 | 129 |
30 Sep 16 | 1,088 | 98 | 303 | 123 |
30 Jun 16 | 1,090 | 78 | 303 | 118 |
31 Mar 16 | 1,083 | 80 | 304 | 117 |
31 Dec 15 | 1,062 | 61 | 301 | 115 |
30 Sep 15 | 1,040 | 62 | 298 | 112 |
30 Jun 15 | 984 | 70 | 291 | 112 |
31 Mar 15 | 946 | 66 | 282 | 108 |
31 Dec 14 | 938 | 73 | 277 | 104 |
30 Sep 14 | 909 | 75 | 269 | 100 |
30 Jun 14 | 931 | 83 | 269 | 99 |
31 Mar 14 | 924 | 89 | 264 | 100 |
31 Dec 13 | 900 | 89 | 259 | 98 |
30 Sep 13 | 906 | 92 | 258 | 98 |
30 Jun 13 | 880 | 86 | 250 | 97 |
Ingresos de calidad: AFX tiene ganancias de alta calidad.
Margen de beneficios creciente: Los actuales márgenes de beneficio(13.2%) de AFX son inferiores a los del año pasado (15.6%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: Los beneficios de AFX han crecido un 19.1% al año en los últimos 5 años.
Acelerando crecimiento: AFX ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.
Beneficios vs. Industria: AFX tuvo un crecimiento negativo de los beneficios (-9.8%) durante el año pasado, lo que dificulta la comparación con la media de la industria Medical Equipment (-9.8%).
Rentabilidad financiera
Alta ROE: La rentabilidad financiera de AFX (12.8%) se considera baja.